CLINICAL_TRIALS
trial_result
· 2019-08-19
Clinical Trial Update: Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN) [Phase 4]
Summary
Phase 4 trial assessing an education and guidance programme to promote Eliquis (apixaban) adherence in non-valvular atrial fibrillation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Non-valvular Atrial Fibrillation | Phase 4 | Status: COMPLETED | Results posted: 2019-08-19